Condition: Sarcoma · Survivorship · Quality of Life (QOL) · Sponsor: Technische Universität Dresden
The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.
This description comes directly from the study's public registry record.
Tanja Strukelj, M. A. · +493514587056 · tanja.strukelj@ukdd.de,
Patricia Blickle, M. Sc. · +49221423506 · patricia.blickle@dkfz-heidelberg.de
Always discuss trial participation with your own doctor first.
| Technical University Dresden | Dresden, Saxony, Germany | Recruiting |
| University Hospital Essen | Essen, Germany | Not Yet Recruiting |
| NCT Heidelberg | Heidelberg, Germany | Recruiting |
| Sarcoma Center Mannheim | Mannheim, Germany | Recruiting |
| Deutsche Sarkom-Stiftung | Wölfersheim, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07148193